(MedPage Today) — SEATTLE — Once-weekly navepegritide and lonapegsomatropin boosted growth in children with achondroplasia, the most common form of dwarfism, according to interim findings from a small phase II trial.
In 12 treatment-naive…
Source link : https://www.medpagetoday.com/meetingcoverage/asbmr/117373
Author :
Publish date : 2025-09-09 15:56:00
Copyright for syndicated content belongs to the linked Source.
